Turid Aas

16.2k total citations · 3 hit papers
59 papers, 11.5k citations indexed

About

Turid Aas is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Turid Aas has authored 59 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 25 papers in Cancer Research and 19 papers in Molecular Biology. Recurrent topics in Turid Aas's work include Breast Cancer Treatment Studies (23 papers), Cancer-related Molecular Pathways (10 papers) and Cancer Genomics and Diagnostics (8 papers). Turid Aas is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Cancer-related Molecular Pathways (10 papers) and Cancer Genomics and Diagnostics (8 papers). Turid Aas collaborates with scholars based in Norway, Sweden and Denmark. Turid Aas's co-authors include Per Eystein Lønning, Stephanie Geisler, Hilde Johnsen, Anne‐Lise Børresen‐Dale, Thérese Sørlie, Charles M. Perou, David Botstein, Patrick O. Brown, Matt van de Rijn and Stefanie S. Jeffrey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Genetics.

In The Last Decade

Turid Aas

57 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2001 8.3k citations Thérese Sørlie, Charles M. Perou et al. profile →
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1996 608 citations Turid Aas, Stephanie Geisler et al. profile →
Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

1999 531 citations Charles M. Perou, Thérese Sørlie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Turid Aas Norway	28	5.7k	5.7k	5.3k	2.0k	1.3k	59	11.5k
Anne‐Lise Børresen‐Dale Norway	18	6.0k 1.1×	6.3k 1.1×	6.1k 1.1×	1.7k 0.8×	1.4k 1.1×	26	12.4k
Rumiko Tashima Japan	10	5.6k 1.0×	5.1k 0.9×	5.4k 1.0×	1.5k 0.8×	1.2k 0.9×	21	11.5k
Øystein Fluge Norway	25	6.4k 1.1×	6.5k 1.1×	6.1k 1.1×	1.7k 0.8×	1.8k 1.3×	91	13.9k
Yasuo Toyozumi Japan	14	5.8k 1.0×	5.2k 0.9×	5.5k 1.0×	1.5k 0.8×	1.3k 1.0×	37	11.8k
Mamiko Fujisue Japan	11	5.5k 1.0×	5.1k 0.9×	5.4k 1.0×	1.5k 0.8×	1.2k 0.9×	18	11.4k
Philip S. Bernard United States	36	5.2k 0.9×	5.0k 0.9×	5.6k 1.1×	1.3k 0.7×	1.3k 0.9×	91	11.2k
Stephanie Geisler Norway	21	7.4k 1.3×	7.5k 1.3×	7.2k 1.4×	2.5k 1.2×	1.7k 1.3×	36	14.5k
Laura van ‘t Veer United States	46	5.1k 0.9×	7.9k 1.4×	5.9k 1.1×	3.0k 1.5×	1.5k 1.1×	200	14.6k
Tomofumi Osako Japan	19	6.0k 1.1×	5.2k 0.9×	5.7k 1.1×	1.6k 0.8×	1.3k 1.0×	42	12.1k
Yasuyuki Nishiyama Japan	16	5.7k 1.0×	5.4k 1.0×	5.4k 1.0×	1.5k 0.8×	1.2k 0.9×	38	12.0k

Countries citing papers authored by Turid Aas

Since Specialization

Citations

This map shows the geographic impact of Turid Aas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turid Aas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turid Aas more than expected).

Fields of papers citing papers by Turid Aas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Turid Aas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turid Aas. The network helps show where Turid Aas may publish in the future.

Co-authorship network of co-authors of Turid Aas

This figure shows the co-authorship network connecting the top 25 collaborators of Turid Aas. A scholar is included among the top collaborators of Turid Aas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Turid Aas. Turid Aas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aas, Turid, et al.. (2025). Distinct clinicopathological features and treatment differences in breast cancer patients of young age. Scientific Reports. 15(1). 5655–5655.

Aas, Turid, Ingeborg Winge, Karin Collett, et al.. (2025). Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer. The Journal of Pathology Clinical Research. 11(6). e70050–e70050.

Tegnander, A., Kristi Krüger, Erling A. Høivik, et al.. (2024). Age‐related phenotypes in breast cancer: A population‐based study. International Journal of Cancer. 154(11). 2014–2024. 4 indexed citations

Bollerslev, Jens, Kristin Godang, Morten Wang Fagerland, et al.. (2023). Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary Hyperparathyroidism. Journal of Bone and Mineral Research. 38(3). 372–380. 13 indexed citations

Heck, Ansgar, Morten Wang Fagerland, Kristin Godang, et al.. (2022). Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation. Annals of Internal Medicine. 175(6). 812–819. 27 indexed citations

Deng, Wei, Jürgen Geisler, Stephanie Geisler, et al.. (2022). Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. Genome Medicine. 14(1). 86–86. 10 indexed citations

Hellström, Mikael, Morten Wang Fagerland, Kristin Godang, et al.. (2020). Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-Study). Journal of Bone and Mineral Research. 36(1). 3–11. 32 indexed citations

Kvaløy, Jan Terje, Kirsten Lode, Ragna Lind, et al.. (2019). Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database. Breast Cancer Research and Treatment. 177(1). 185–195. 18 indexed citations

Akslen, Lars A., Ellen Schlichting, Turid Aas, et al.. (2018). Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study. European Thyroid Journal. 8(1). 31–40. 32 indexed citations

10.

Wik, Elisabeth, et al.. (2017). Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. PLoS ONE. 12(2). e0171853–e0171853. 23 indexed citations

11.

Aas, Turid, et al.. (2017). Diet in women with breast cancer compared to healthy controls – What is the difference?. European Journal of Oncology Nursing. 32. 20–24. 8 indexed citations

12.

Hofvind, Solveig, Åsne Sørlien Holen, Turid Aas, et al.. (2015). Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. European Journal of Surgical Oncology. 41(10). 1417–1422. 84 indexed citations

13.

Høberg‐Vetti, Hildegunn, Cathrine Bjorvatn, Bent Fiane, et al.. (2015). BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study. European Journal of Human Genetics. 24(6). 881–888. 51 indexed citations

14.

Brauckhoff, Michael, et al.. (2014). Latencies longer than 3.5 ms after vagus nerve stimulation does not exclude a nonrecurrent inferior laryngeal nerve. BMC Surgery. 14(1). 61–61. 3 indexed citations

15.

Akslen, Lars A., Oddbjørn Straume, Stephanie Geisler, et al.. (2011). Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer. British Journal of Cancer. 105(1). 9–12. 13 indexed citations

16.

Lønning, Per Eystein, et al.. (2009). Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status. The Journal of Steroid Biochemistry and Molecular Biology. 117(1-3). 31–41. 76 indexed citations

17.

Sørlie, Thérese, Charles M. Perou, Huihui Fan, et al.. (2006). Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Molecular Cancer Therapeutics. 5(11). 2914–2918. 97 indexed citations

18.

Geisler, Stephanie, Per Eystein Lønning, Turid Aas, et al.. (2001). Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.. PubMed. 61(6). 2505–12. 264 indexed citations

19.

Aasly, Jan, H. Silfvenius, Turid Aas, et al.. (1999). Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Research. 35(3). 211–217. 43 indexed citations

20.

Ellis, PA, Per Eystein Lønning, A.L. Børresen-Dale, et al.. (1997). Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. British Journal of Cancer. 76(4). 480–485. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact